investig
proport
mono
vs
mix
infect
human
metapneumoviru
hmpv
compar
adenoviru
adv
four
type
coronaviru
crv
parainfluenza
viru
piv
rsv
enterovirusrhinoviru
erv
alberta
canada
use
data
integr
alberta
laboratori
dial
platform
respiratori
specimen
provlab
juli
june
select
includ
studi
use
respiratori
viru
panel
specimen
test
posit
one
respiratori
viru
neg
influenza
b
subset
hmpv
fourth
common
viru
identifi
mix
infect
use
dial
mix
infect
hmpv
commonli
found
infant
less
month
old
erv
commonli
found
mix
infect
hmpv
virus
across
age
group
proport
mixedinfect
vs
monoinfect
highest
adv
follow
crv
crv
crv
crv
piv
rsv
hmpv
erv
hmpv
significantli
like
identifi
mono
infect
compar
adv
crv
piv
rsv
except
erv
p
respiratori
tract
infect
global
public
health
concern
canada
eighth
lead
caus
death
human
metapneumoviru
hmpv
rna
viru
belong
paramyxovirida
famili
viru
identifi
research
netherland
import
caus
respiratori
infect
affect
age
group
studi
saskatchewan
canada
liu
et
al
use
elisa
show
seropreval
hmpv
approach
young
adulthood
viru
affect
age
group
sever
studi
shown
hmpv
lead
caus
lower
respiratori
tract
infect
children
also
affect
elderli
clinic
manifest
similar
respiratori
syncyti
viru
rsv
primarili
lead
pneumonia
bronchiol
canada
outbreak
associ
hmpv
report
alberta
british
columbia
quebec
mainli
long
term
senior
care
facil
common
respiratori
virus
set
includ
influenza
flua
influenza
b
flub
parainfluenza
viru
piv
enterovirusrhinoviru
erv
adenoviru
adv
coronaviru
crv
caus
lower
respiratori
tract
infect
provinci
laboratori
public
health
provlab
alberta
provid
test
respiratori
viru
pathogen
provinc
alberta
surround
northern
territori
exclud
yukon
canada
diagnost
test
algorithm
respiratori
viru
provlab
chang
pandem
april
respiratori
specimen
arriv
provlab
screen
inhous
realtim
reversetranscriptas
rt
pcr
influenza
specimen
posit
influenza
also
subtyp
season
season
pandem
gene
rtpcr
cost
effect
approach
adopt
june
test
specimen
neg
influenza
b
either
singleplex
multiplex
real
time
pcr
assay
use
respiratori
viru
panel
rvp
classic
assay
multiplex
assay
detect
multipl
respiratori
viral
pathogen
includ
flua
flub
piv
erv
adv
type
crv
rsv
hmpv
except
test
polici
includ
sampl
submit
provinci
influenzalikeil
surveil
program
tarrant
viral
watch
sampl
patient
sever
ill
admiss
intens
care
unit
alberta
uniqu
platform
develop
laboratorybas
surveil
call
data
integr
alberta
laboratori
dial
dial
secur
web
base
platform
use
extract
interpret
collat
analyz
respiratori
viru
test
data
provlab
laboratori
inform
system
li
real
time
dial
automat
engin
extract
raw
specimenbas
laboratori
data
provlab
li
includ
patient
demograph
inform
physician
submit
agenc
test
data
specif
target
second
import
compon
dial
builtin
autom
interpret
engin
aie
provid
clinic
relev
interpret
final
targetspecif
classif
specimen
final
dial
also
analyt
engin
allow
user
select
creat
specif
data
set
variou
target
differ
factor
eg
patient
demograph
geograph
distribut
time
period
test
method
perform
differ
type
analysi
includ
graphic
present
tabl
map
rate
calcul
trend
analysi
case
respiratori
specimen
provlab
dial
aie
design
assign
posit
neg
classif
respiratori
viru
well
summari
classif
classifi
specimen
posit
one
specif
viru
mix
infect
one
respiratori
viru
neg
respiratori
virus
use
final
classif
posit
neg
specimen
viru
easili
select
dial
analysi
studi
use
dial
select
specimenbas
data
investig
proport
mono
vs
mix
infect
hmpv
compar
adv
crv
erv
piv
rsv
period
three
year
juli
june
order
creat
uniform
dataset
studi
exclud
sampl
test
posit
influenza
b
inhous
realtim
pcr
assay
includ
sampl
undergon
rvp
test
use
dial
specimen
identifi
posit
one
respiratori
viru
studi
period
total
exclud
studi
test
posit
influenza
influenza
b
influenza
b
specimen
test
rvp
even
though
neg
influenza
rvp
posit
specimen
includ
studi
receiv
juli
june
juli
june
juli
june
mix
infect
one
viru
identifi
found
specimen
monoinfect
one
viru
identifi
major
specimen
collect
upper
respiratori
tract
nasopharyngealnasalthroat
swab
nasopharyng
aspir
respiratori
sampl
unspecifi
sourc
lower
respiratori
tract
eg
endotrach
aspir
bronchaveolar
lavag
remain
unknown
sampl
type
tissu
steril
bodi
fluid
age
distribut
specimen
submit
test
posit
hmpv
summar
tabl
highest
number
specimen
receiv
patient
less
month
old
proport
specimen
test
posit
hmpv
rang
among
differ
age
group
p
chi
squar
test
overal
mix
infect
detect
specimen
test
posit
hmpv
use
specimen
youngest
age
group
less
six
month
old
refer
age
group
signific
differ
proport
mix
hmpv
infect
among
variou
age
group
p
binari
logist
regress
tabl
mix
infect
hmpv
commonli
found
specimen
patient
younger
six
month
rare
specimen
submit
older
year
old
among
specimen
mix
infect
hmpv
three
commonli
found
viru
erv
rsv
piv
also
three
common
virus
detect
specimen
tabl
comparison
adv
four
type
crv
piv
rsv
hmpv
significantli
lower
proport
mix
infect
specimen
bonferroni
correct
p
signific
differ
mix
infect
compar
hmpv
erv
bonferroni
correct
age
distribut
viru
found
mix
infect
hmpv
summar
tabl
erv
commonli
found
viru
hmpv
mix
infect
across
age
group
peak
hmpv
activ
observ
februari
june
novemb
wherea
peak
erv
activ
found
month
septemb
three
consecut
year
figur
specimen
mix
infect
two
virus
follow
trend
circulatori
pattern
hmpv
influenza
b
posit
sampl
sampl
test
rvp
exclud
analysi
specimen
subset
one
viru
identifi
coexist
hmpv
five
specimen
unknown
age
group
tabul
specimen
subset
one
viru
identifi
coexist
hmpv
object
studi
describ
mono
mix
infect
hmpv
jurisdict
three
year
period
specimen
data
acquir
use
provlab
dial
applic
abl
identifi
hmpv
like
occur
mono
infect
mix
result
studi
similar
previou
pilot
studi
alberta
identifi
hmpv
mix
pathogen
specimen
popul
name
hospit
patient
mix
hmpv
infect
minor
studi
also
determin
hmpv
mix
infect
pathogen
like
coexist
hmpv
erv
contrast
studi
identifi
rsv
lead
caus
mix
infect
hmpv
may
sever
reason
differ
find
includ
type
diagnost
assay
use
detect
variou
respiratori
target
clinic
set
patient
age
time
specimen
collect
mani
studi
focus
popul
mostli
consist
hospit
pediatr
patient
studi
shown
rsv
lead
pathogen
identifi
young
children
month
year
old
contrast
studi
examin
age
group
includ
communitybas
hospitalbas
specimen
erv
hmpv
remain
close
link
across
age
group
mix
infect
hmpv
commonli
found
age
group
less
month
old
moreov
erv
still
domin
viru
found
mix
hmpv
data
set
includ
specimen
collect
second
phase
pandem
alberta
northern
territori
made
one
third
specimen
includ
studi
found
sampl
juli
june
test
posit
erv
significantli
higher
found
two
time
period
juli
june
juli
june
p
binari
logist
regress
studi
also
shown
pandem
erv
common
circul
viru
follow
crv
moreov
linkag
erv
hmpv
could
also
due
inclus
larg
group
virus
identifi
erv
sinc
rvp
could
distinguish
variou
strain
rhinoviru
enteroviru
might
also
factor
relat
host
immun
respons
viral
infect
kinet
examin
season
hmpv
erv
mix
infect
two
virus
rel
lower
number
hmpv
mix
infect
six
virus
annual
variat
peak
hmpv
activ
observ
studi
one
peak
month
occur
summer
differ
studi
variou
canadian
provinc
show
peak
hmpv
winter
januari
april
expect
mix
infect
hmpv
erv
follow
circulatori
pattern
hmpv
differ
erv
although
find
shown
trend
hmpv
abil
exist
mono
versu
mix
infect
import
limit
studi
firstli
influenza
b
posit
sampl
exclud
mainli
provlab
routin
test
influenza
posit
specimen
hmpv
sinc
pandem
exclud
influenza
virus
databas
may
impact
viral
coinfect
rate
identifi
studi
hand
recent
studi
england
show
lower
preval
influenza
patient
posit
hmpv
adv
rsv
piv
rhinoviru
statist
signific
relationship
hmpv
rhinoviru
anoth
limit
analysi
age
group
base
specimenbas
data
duplic
sampl
individu
moreov
limit
inform
usual
provid
requisit
submit
specimen
abl
studi
clinic
manifest
monoinfect
versu
mix
infect
explor
differ
set
despit
limit
state
studi
consider
public
health
implic
studi
help
us
better
understand
frequenc
hmpv
mono
versu
mix
infect
period
three
year
better
understand
mechan
condit
support
mono
versu
mix
infect
differ
clinic
present
prognosi
need
preval
viru
support
research
effort
develop
vaccin
strategi
may
becom
avail
futur
also
bring
us
question
whether
test
algorithm
provlab
need
chang
better
understand
interact
hmpv
influenza
b
sinc
hmpv
shown
import
pathogen
includ
ongo
surveil
public
health
strategi
enhanc
surveil
program
help
us
better
understand
hmpvassoci
diseas
maintain
awar
trend
mono
mix
infect
provlab
provid
respiratori
viru
test
provinc
alberta
surround
northern
territori
exclud
yukon
canada
sinc
june
respiratori
specimen
arriv
provlab
screen
inhous
rt
pcr
influenza
specimen
test
posit
influenza
also
subtyp
season
season
pandem
gene
rtpcr
multiplex
assay
detect
influenza
b
implement
februari
specimen
test
neg
influenza
b
test
use
rvp
classic
assay
multiplex
assay
detect
multipl
respiratori
viral
pathogen
includ
flua
flub
piv
erv
adv
four
type
crv
rsv
hmpv
except
test
polici
includ
sampl
submit
provinci
influenzalikeil
surveil
program
tarrant
viral
watch
sampl
patient
sever
ill
admit
intens
care
unit
specimen
test
rvp
test
posit
one
respiratori
viru
exclud
influenza
b
juli
june
identifi
use
dial
applic
includ
studi
dial
provid
classif
specimen
respiratori
viru
target
well
mono
versu
mix
infect
dial
also
allow
user
select
specimen
base
type
test
variou
geograph
time
period
age
group
statist
analysi
proport
mono
versu
mix
infect
differ
viru
perform
use
pearson
chisquar
test
bonferroni
adjust
multipl
analys
proport
hmpv
mix
infect
age
group
erv
posit
specimen
analysi
age
group
time
period
analyz
use
binari
logist
regress
spss
softwar
version
statist
ibm
corp
usa
use
statist
analysi
level
signific
set
p
studi
use
dial
provid
userdefin
data
set
respiratori
viru
test
data
found
period
year
juli
june
hmpv
significantli
like
identifi
mono
infect
compar
adv
four
type
crv
piv
rsv
except
erv
three
virus
like
found
mix
infect
hmpv
studi
erv
piv
rsv
higher
proport
mix
infect
found
young
infant
